Changes in Bone Turnover With Increased Incretin Hormone Exposure
Status:
Terminated
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the use of sitagliptin increases bone formation
and reduces bone turnover in postmenopausal women with type 2 diabetes.